Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma.
about
Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function.Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies.The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.
P2860
Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy and safety of everoli ...... tastatic renal cell carcinoma.
@ast
Efficacy and safety of everoli ...... tastatic renal cell carcinoma.
@en
type
label
Efficacy and safety of everoli ...... tastatic renal cell carcinoma.
@ast
Efficacy and safety of everoli ...... tastatic renal cell carcinoma.
@en
prefLabel
Efficacy and safety of everoli ...... tastatic renal cell carcinoma.
@ast
Efficacy and safety of everoli ...... tastatic renal cell carcinoma.
@en
P2093
P2860
P50
P1476
Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
@en
P2093
Hyo Song Kim
Ki Hyang Kim
Sang Hyun Yoon
P2860
P2888
P304
P356
10.1007/S00280-013-2266-Y
P577
2013-08-27T00:00:00Z
P6179
1020346870